Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulating the Glucose-dependent Insulinotropic Polypeptide (GIP) System in Patients With Acromegaly Due to a Pituitary Tumor

NCT03807076 is registered in ClinicalTrials.gov with University of Copenhagen as lead sponsor.

NCT NCT03807076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03807076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulating the Glucose-dependent Insulinotropic Polypeptide (GIP) System in Patients With Acromegaly Due to a Pituitary Tumor
Lead sponsor
University of Copenhagen
Phase
Not applicable
Overall status
Completed
Start date
August 13, 2019
Completion date
November 28, 2023
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acromegaly due to pituitary adenoma